DCF — OVIEDO MEDICAL CENTER
Enterprise Value: $63.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$63.3M
Enterprise Value
$15.8M
PV of Cash Flows
$47.5M
PV of Terminal Value
$76.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $114.3M | $9.0M | 8.0% | $2.6M | $2.4M |
| Year 2 | $117.7M | $10.4M | 9.0% | $3.6M | $3.0M |
| Year 3 | $121.2M | $12.0M | 10.0% | $4.6M | $3.4M |
| Year 4 | $124.9M | $12.9M | 10.0% | $5.2M | $3.5M |
| Year 5 | $128.6M | $13.6M | 11.0% | $5.6M | $3.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $63.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$110.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07358959119943433
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5